Related Experiment Video
Updated: Mar 9, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever
Hala M Lofty1, Huda Marzouk1, Yomna Farag1
1Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.
Insights
Serum amyloid A (SAA) levels remain elevated in most Egyptian children with familial Mediterranean fever (FMF) even after attacks. This suggests ongoing subclinical inflammation, making SAA a potential marker for monitoring FMF activity.
Area of Science:
- Rheumatology
- Pediatrics
- Immunology
Background:
- Serum amyloid A (SAA) is an acute-phase reactant associated with inflammatory conditions like familial Mediterranean fever (FMF).
- Elevated SAA levels may correlate with an increased risk of developing amyloidosis.
- Understanding SAA levels in pediatric FMF is crucial for monitoring disease activity and potential complications.
Purpose of the Study:
- To measure serum amyloid A (SAA) levels in Egyptian children diagnosed with familial Mediterranean fever (FMF).
- To investigate potential correlations between SAA levels and demographic factors or clinical manifestations in pediatric FMF patients.
- To explore the relationship between SAA levels and specific genetic variants or colchicine adherence in FMF.
Main Methods:
- The study included seventy-one Egyptian children diagnosed with familial Mediterranean fever (FMF).
- Serum amyloid A (SAA) levels were measured in all participants.
- Demographic data, clinical manifestations, genetic variants (V726A, M694V), and colchicine adherence were assessed.
Main Results:
- A high SAA level was observed in 78.9% of the studied pediatric FMF patients, with a mean level of 81.62 ± 31.6 mg/L.
- No significant correlation was found between SAA levels and demographic data or clinical symptoms.
- Elevated SAA levels were more frequent in patients with the V726A allele and those with low adherence to colchicine therapy.
Conclusions:
- High serum amyloid A (SAA) levels are prevalent in Egyptian children with familial Mediterranean fever (FMF), persisting even two weeks post-attack.
- This suggests the presence of subclinical inflammation during attack-free periods in pediatric FMF.
- SAA may serve as a valuable biomarker for detecting and monitoring ongoing inflammation in FMF patients, particularly in the pediatric population.
Abstract:
Background and Objectives. SAA is an acute-phase reactant detected during an FMF attack or other inflammatory conditions. High SAA levels may increase the risk of amyloidosis. The aim of the study is to measure the serum amyloid A (SAA) level in a group of Egyptian children with familial Mediterranean fever (FMF) and study its various correlates, if any. Methods. The study enrolled seventy-one children with FMF. Results. SAA level was high in 78.9% of the studied patients with a mean of 81.62 ± 31.6 mg/L, and CRP was positive in 31% of patients. There was no significant releation between SAA level and any demographic or clinical manifestation. High SAA was more frequent in V726A allele (16.9%) followed by M694V allele (12.3%). Elevated SAA levels were more frequent in patients on low colchicine doses. Forty-five percent (45%) of patients have low adherence to colchicine therapy. Interpretation and Conclusion. High SAA levels were detected two weeks after last FMF attack in a large percentage of Egyptian FMF children. This indicates that subclinical inflammation continues during attack-free periods, and SAA could be used as a marker of it.
Related Concept Videos
Serum Studies: Renal Function Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Nephrotic Syndrome II : Assessment and Medical Management
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

